Mutations in ARL6/BBS3 account for Bardet-Biedl syndrome-3 (OMIM #600151), which is characterized by retinal dystrophy, renal structural abnormalities, history of obesity, and skeletal abnormalities. Here, ARL6 is linked to obesity due to melanocortin 4 receptor deficiency.